BeStock  
Markets › Compare › TSHA vs AVLN

TSHA vs AVLN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TSHA · Taysha Gene Therapies$3.72 ▼ 1.33%
AVLN · Avalyn Pharma$28.40 ▼ 1.05%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

507294116138Apr 30, '26Aug 12, '26Nov 20, '26
  • TSHA -41.8%
  • AVLN -3.7%

Head to head

MetricTSHAAVLN
Price$3.72$28.40
Change today▼ 1.33%▼ 1.05%
Market cap$1.21B$1.26B
Return, 3 months-37.7%-24.6%
Return, year to date-32.4%–
Return, 1 year-11.2%–
P/E (TTM)––
P/B3.43.4
P/E percentile vs own 5y22nd74th
Dividend yield––
Revenue growth (YoY, latest qtr)-100.0%–
Net profit growth (YoY)-73.5%-43.3%
Gross margin––
Operating margin-2,854.9%–
Net margin-2,728.0%–
Return on equity-47.1%-25.9%
Analyst target vs. price+285.2%+111.3%
Analyst buy share100%100%
RSI (14)3551
30-day volatility74.4%62.3%
Max drawdown, 1 year-49.7%-40.6%
Trend readStrong downtrendStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AVLN is the largest of the group by market value.
  • AVLN has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top